Home・Stock List・Twist Bioscience Corp

Twist Bioscience Corp

Closed

SectorHealthcare

115.68 6.66

Buy Sell

Overview

Share price change

24h

Current

Min

108.24

Max

114.17

Key metrics
By Trading Economics
Income	9M -35M
Sales	7.7M 118M
EPS	-0.56
Profit margin	-29.61
Employees	979
EBITDA	1.5M -36M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	-4.46% downside

Market Stats
By TradingEconomics
Market Cap	2.8B 6.3B
Previous open	109.02
Previous close	115.68

News Sentiment

By Acuity

69%

31%

306 / 340 Healthcare

Twist Bioscience Corp Chart

Past performance is not a reliable indicator of future results.

Related News

5 Aug 2026, 23:56 UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

4 Aug 2026, 23:01 UTC

News

Twist Bioscience announced a $250 million public offering, raising concerns over potential dilution. Shares are trading lower in after-market hours following the announcement.

3 Aug 2026, 22:16 UTC

Twist Bioscience Corp shares are lower in after-market hours, despite an initial gain following Monday's close. No specific news was identified to explain the decline.

31 Jul 2026, 19:56 UTC

Twist Bioscience shares are higher, reflecting positive sentiment in biotechnology amid strong results from major technology firms like Amazon.

30 Jul 2026, 10:16 UTC

Twist Bioscience Corp is trading slightly higher in pre-market hours, recovering from a decline in the previous session amid broader tech stock volatility.

29 Jul 2026, 19:36 UTC

Correlated Moves

Macro Event

Twist Bioscience shares are lower today, influenced by a declining Russell 2000 Index and persistent inflation concerns amid steady interest rates.

28 Jul 2026, 21:56 UTC

Twist Bioscience Corp shares are trading lower in after-market hours. Broader market trends, including declines in Asian semiconductor stocks, may be influencing this movement.

27 Jul 2026, 19:33 UTC

Twist Bioscience Corp shares are lower today, continuing a recent downward trend. The stock pulled back significantly after reaching a session high.

24 Jul 2026, 15:24 UTC

Twist Bioscience Corp shares are lower today, reversing a recent trend of gains. High trading volume accompanies the decline amid mixed economic signals.

21 Jul 2026, 20:02 UTC

Correlated Moves

Twist Bioscience Corp is advancing today, supported by high trading volume and renewed investor interest in technology and AI stocks, despite a pullback earlier in the session.

20 Jul 2026, 23:06 UTC

Twist Bioscience Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

Peer Comparison

Price change

Twist Bioscience Corp Forecast

Price Target

By TipRanks

-4.46% downside

12 Months Forecast

Average 109.88 USD -4.46%

High 120 USD

Low 95 USD

Based on 9 Wall Street analysts offering 12 month price targets forTwist Bioscience Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Twist Bioscience Corp - Dist in the past 3 months.

Sentiment

By Acuity

306 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.